Status:
COMPLETED
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Genetic Disorder
Achondroplasia
Eligibility:
All Genders
Brief Summary
This study is conducted in Japan. The aim of the study is to evaluate the efficacy of somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia / hypochondroplasia enrolled in the...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who were enrolled in the GH-1941 study (1997 to 2006) and expected to theoretically reach the adult height within the study period
Exclusion
Key Trial Info
Start Date :
November 22 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 4 2015
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT01435629
Start Date
November 22 2012
End Date
December 4 2015
Last Update
May 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Tokyo, Japan, 1000005